KRUTI PATEL DO NPI 1700273760

NPI Details

Kruti Patel, DO is a hematology and oncology internal medicine in Cincinnati, OH with 11 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Kruti Patel, DO NPI is 1700273760. The provider is registered as an individual entity type and is a multi-specialty group.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: LINCOLN MEM UNIV, DEBUSK COL OF OSTEOPATHIC MED
Graduation Year:2015

The provider's business location address is:

4777 E GALBRAITH RD STE 320
CINCINNATI, OH
ZIP 45236-725
Phone: (513) 751-2273

The NPI 1700273760 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Magnesium level (HCPCS:83735)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Folic acid level, serum (HCPCS:82746)
• Uric acid level, blood (HCPCS:84550)
• Injection of drug or substance into vein (HCPCS:96374)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Phosphate level (HCPCS:84100)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 4/16/2015 and was last updated on 6/24/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: